The residues of the inhibitor are labeled without a chain designator. The residues of the enzyme are marked "e", except for the first residue, marked "p" (E1p), which belongs to the prosegment sequence.
INTRODUCTION
An estimated 18 million people in Central and South America are infected with the protozoan pathogen Trypanosoma cruzi and about 120 million are at risk. Up to 30% of those infected with the parasite will develop the irreversible medical condition known as Chagas disease, with fatal prognosis. The protozoan causing Chagas disease is related to those causing African sleeping sickness and leishmaniasis, but the insect vector, Triatoma infestans, is different.
T. cruzi expresses a potent papain-like (C1 family) cysteine protease, called cruzipain or cruzain, which is the main antigen recognized by the immune system at infection and is essential both for the life-cycle of the parasite and for its interaction with host cells. Because of these properties, the enzyme is a promising target for therapy and it has indeed been demonstrated that synthetic cysteine protease inhibitors strongly limit the parasitic replication both in cell culture and in mice. 1 The natural regulation of cruzipain in T. cruzi is largely unknown. It can be assumed that, as in other uni-and multicellular organisms, a balance exists between cysteine protease(s) and specific inhibitor(s). In a variety of species, from mammals, fish, plants, and insects to simpler eukaryotic organisms such as the filarial parasites Onchocerca volvulus and Acanthocheilonema viteae, cysteine proteases are in equilibrium with inhibitors of the cystatin family I25. 2,3,4,5 Most cystatins are single-domain proteins composed of 100-120 residues with a characteristic fold presenting the N-terminal segment and two β-hairpin loops for complementation of the active site cleft of the target enzyme. 6 They show high affinity for their target enzymes, with equilibrium constants for dissociation of the formed complexes (K i ) typically in the range of 10 -9 -10 -11 M, but these can even be as low as 10 -14 M, as in the case of the human cystatin C -papain complex. 7 A completely different structure resulting in a similar high-affinity inhibition of certain papain-like cysteine proteases is represented by the p41 fragment of the MHC class II-associated invariant chain, originally isolated from human kidney, as a complex with cathepsin L. The p41 fragment is smaller than cystatins (64 amino acid residues), but exhibits a similar mode of enzyme inhibition that utilizes three loop fragments forming a wedge to cover the active site cleft; it binds with high affinity (K i 10 -9 -10 -12 M for cathepsin L, cruzipain, and papain).
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Evidence has been presented that trypanosomatids, such as various Trypanosoma and Leishmania species, contain cystatin-like inhibitors of their own family C1 proteases. 10 Searching for such an inhibitor in T. cruzi, we identified and cloned chagasin, a potent reversible inhibitor of cruzipain, with an appropriate size (110 amino acid residues), but no obvious sequence similarity to cystatins (GenBank/EMBL Acc. No. AJ299433).
11 Subsequent identification and partial characterization of chagasin in T. cruzi extracts showed that it indeed functions very much like a cystatin, showing high-affinity and tight-binding inhibition of papain and cruzipain. 12 Early molecular modeling studies predicted an immunoglobulin-like fold for chagasin, 13 which was essentially confirmed by a recent NMR study 14 and an X-ray analysis of chagasin crystallized in the presence of polyethylene glycol (PEG). 15 Despite this progress in the elucidation of the chagasin structure, the key issue of the mechanism of inhibition has been left to conjecture, based only on modeling 15, 16 and cursory NMR data 14 .
In the present study, we present a high-quality crystallographic structure of chagasin in complex with human cathepsin L, which is a potential target enzyme during T. cruzi infection. The results confirm mapping of the enzyme-binding epitope to three loops and illustrate the degree of structural adjustments as well as precise atomic contacts formed during enzyme binding. These aspects of chagasin inhibition, in particular the conformational adjustment of one of the inhibitory loops, were impossible to accurately predict in the earlier modeling studies. Chagasin inhibits the enzyme by inserting one loop into the active site and by using two lateral loops for docking on target surfaces, with a different mode of interaction exploited by each loop. Detailed knowledge of the structure and inhibition mode of chagasin will guide the development of drugs for possible prevention and treatment of Chagas disease.
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RESULTS

Properties of chagasin
A cDNA fragment encoding the 110 residues of native chagasin was amplified from the fulllength T. cruzi clone Tc18 11 and subcloned in the expression vector pGEX-6P to produce a GSTchagasin fusion protein in E. coli. Complete DNA sequencing of the insert in the expression vector verified that the recombinant protein was encoded as intended, i.e. with 110 residues of native chagasin (Fig. 1a) sequence plus five extra residues at the N-terminus (GPLGS) derived from the expression vector construct. After glutathione affinity chromatography and proteolytic cleavage of the fusion protein, chagasin could be purified to homogeneity by ion exchange chromatography. and k on values, the rate constant for dissociation (k off ) was 4.0 x 10 -4 s -1 , agreeing with that estimated from the progress curves (7.3 x 10 -4 s -1 ). 17 Analysis of the chagasin interactions with other cysteine proteases shows that the inhibition of cathepsin L and the cathepsin L-like T. cruzi enzyme, cruzipain, is in the range of 0.0039 to 0.018 nM (Table 1) . Although with lower affinity, chagasin can also inhibit human cathepsin B, which several cystatins fail to do (Table 1) .
Crystallization and structure determination
Recombinant chagasin, Se-Met-substituted chagasin, and a complex of native recombinant chagasin with the human cysteine protease cathepsin L were all subjected to crystallization trials.
Cathepsin L used in these studies was produced by Pichia pastoris expression and purified to homogeneity. The expression vector insert was mutated to replace the catalytically active C25
residue with an alanine (C25A), but otherwise encoded native procathepsin L. The procathepsin L was converted to the mature form by addition of catalytic amounts of active recombinant wildtype cathepsin L, after which the mature cathepsin L was isolated by ion exchange chromatography. Complex formation between chagasin and cathepsin L was carried out directly in the crystallization drops, as detailed in the Materials and Methods section.
Crystals of native chagasin were obtained using either lithium sulfate or ammonium sulfate as precipitants. Although the crystals from ammonium sulfate were larger and better formed, they cracked on flash-freezing. Consequently, X-ray diffraction data were collected for the crystals obtained with lithium sulfate, using 10% glycerol as cryoprotectant. The crystals of Se-Met chagasin were grown from protein solutions of lower concentration and with a higher precipitant concentration; they did not require any additional cryoprotection.
The crystal structure of chagasin solved from Se-MAD data revealed two molecules (A and B) in the asymmetric unit. The refinement was carried out using the native data set extending to 1.7 Å resolution. The main chain of both chagasin molecules corresponding to the native amino acid sequence could be traced end-to-end without breaks in the 2F o -F c electron density map at the 1.2σ level and all the side chains are visible at the 0.8σ level.
Single crystals of the chagasin-cathepsin L complex were obtained using the initial screening (see Materials and Methods). The 1.75 Å resolution structure of the complex was solved by molecular 
Description of the chagasin structure
Although the structures of T. cruzi chagasin and of its Leishmania mexicana homologue have been reported recently, 14, 15, 16 a brief overview of our high-resolution crystal structure of free chagasin is useful. The chagasin molecule is composed almost exclusively of β-strands (Fig. 1a) and can be considered as a split β-barrel formed by two β-sheets, whose edges do not meet. Four β-strands, β1, β3, β6 and β5, on one side of the barrel, create a sheet with a predominately antiparallel architecture, in which only strand β1 is parallel to its neighbor (Fig. 1b) . The second β-sheet, created by strands β2, β8, β7 and β4, is also predominantly antiparallel, with only β2 parallel to its neighbor. The space between the sheets is filled with a large number of hydrophobic side chains. The only exception is E71, forming a contact with the main-chain N atom of W36. It has been noted before that this topology resembles a distorted immunoglobulin fold 13 . The distortion, however, is quite extensive and can be described as an insertion of the β1-loop-β2 motif, which violates the parallel character of both constituent β-sheets. A prominent feature of this folding scheme is the clustering of loops at each end of the barrel. Loops L1, L3
and L5 on one side of the molecule are compact and do not stick out from the molecule. Loops L1 and L5 are short, composed of four and three residues, respectively. The L3 loop, consisting of residues E39-M50 is much longer; it traces a semi-helical turn in its N-terminal part, but despite this it does not protrude from the molecular outline. Loop L3 assumes two clearly distinguishable conformations in molecule A, but both of them are different from the single conformation observed in molecule B.
Loops L2, L4 and L6 are located at the opposite end of the molecule. The connection between 9 strands β1 and β2 on the same side of the β-barrel forms a tight turn with 3 10 geometry (Fig. 1c) .
The three broad loops L4, L2 and L6 are located one after another in an approximately coplanar alignment resembling a fan. Loop L4 is created by residues P59-G68 and loop L2 by residues N29-F34, with a single 3 10 -helical turn at its apex. Loop L6, made up of residues R91-S100, is large and takes the form of two turns.
Overall, the shape and the functional elements of the chagasin molecule are reminiscent of a "three-prong plug", with the prongs created by the loops L4, L2 and L6 as the enzyme-binding region ( Fig. 1) .
Comparison of the two crystallographic copies of the free chagasin molecule
The molecules A and B of free chagasin are very similar ( i.e. at the N terminus and in loop L3. In addition, a few surface side chains, such as E44, E48, N47, E54, K56, K63, H98, D99, R102, and N110, have slightly different conformations.
Comparison of free chagasin and chagasin in complex with cathepsin L
Comparison of the free chagasin structure with the chagasin molecule in complex with cathepsin L shows that the molecule does not change its general fold upon binding to the enzyme (Fig. 1b) .
The overall r.m.s. deviation between the corresponding Cα atoms is 0.5 Å (Table 2 ). An important exception is loop L4, which undergoes a large conformational change corresponding to 4.5 Å at the Cα atom of K63. An even larger movement is observed for the side chain of this lysine residue, where the terminal nitrogen atom moves by 13.1 Å. In the altered conformation, the L4 loop can form a number of contacts with the enzyme, as described below. In particular, the amino group of K63 forms, in one of two alternate conformations, a hydrogen bond with the OH group of Y72e. The other elements of the enzyme-binding epitope (loops L2 and L6) do not change conformation upon docking to cathepsin L. The movement of other side chains is not large and is limited to some solvent-exposed residues.
The chagasin-cathepsin L interface
The polypeptide chain of cathepsin L in the chagasin complex starts with residue E1p, which is the last residue of the propeptide sequence 19 (UniProtKB/Swiss-Prot P07711). 20 This residue is highly mobile and has been modeled in two conformations. The next residue, A1e, which is the first residue of the native cathepsin L sequence, is well defined in the electron density. The last residue, V220e, is stabilized by a hydrogen bond with the -NH 3 + group of K41e. The primary structure of the enzyme corresponds to the native sequence, except for the catalytic C25e residue, which has been mutated to alanine. The residue N108e, which is part of a glycosylation consensus sequence 21 , is partially glycosylated and two NAG sugar units with fractional occupancy have been modeled.
The cathepsin L structure in the present chagasin complex is very similar to the high-resolution structure of procathepsin L (PDB code 1CS8), the r.m.s. deviation between the Cα atoms being 0.35 Å. The only significant discrepancy is observed in the loop formed by residues E173e-N180e. This loop is very flexible as attested by the high atomic B-factors in this region. It has a blunt tip and forms two turns, E173e-E176e and S177e-N180e. This conformation is influenced by a crystal contact of the side chain amide group of N179e with the carboxyl group of E192e from a symmetry-related cathepsin L molecule. Additionally, the disordered side chain of E176e forms close contacts with the main-chain carbonyl of residue N179e and with the side chain carboxyl of E173e in its two orientations. The side-chain hydroxyl group of S177e forms a hydrogen bond with the main-chain carbonyl of T175e, serving as a "clip" in the middle of the flexible loop and creating the two turns mentioned above.
The overall shape of the complex resembles an inverted mushroom, with the stalk formed by the cylindrical chagasin molecule and the cap by the globular cathepsin L (Fig. 2a) . The active site of cathepsin L is located in a long cleft running across the whole molecule, with the sides constituting the L-and R-domains of a typical papain-like cysteine protease. 22 One side of this cleft is formed by residues H140e-Y146e, in helical conformation, and the loop S157e-D162e of the L-domain. The other side of the cleft is created by loops N18e-A25e and N62e-G68e of the R-domain. The bottom of the cleft is made up of loops E159e-H163e and N187e-E191e. The catalytic triad C25e-H163e-N187e is located in the middle and at the bottom of the cleft. In the construct used in the present study, the nucleophilic C25e residue had been mutated to an alanine.
The binding region of chagasin, composed of loops L2, L4, and L6, binds very tightly to the cathepsin L molecule. The main hydrogen bonds between chagasin and cathepsin L in the complex are listed in Table 3 . All three loops are located in the catalytic groove, with the central loop L2 inserted directly into the catalytic center. Loops L4 and L6 embrace the enzyme molecule from both sides (Fig. 2b ).
The interactions of each loop have distinctly different character. Compared to the very strong and extended interactions of loops L4 and L6, the interactions of loop L2 are very limited. Its 3 10 -helical turn is inserted directly into the active site but makes only two contacts with the enzyme (Fig. 2c ). An effect of a repulsive contact is seen between the carbonyl O atom of T31 and the Nδ1 atom of the imidazole ring of the catalytic H163e residue. A much longer, attractive contact exists between the same T31 carbonyl and the Nε1 atom of W189e (Table 3 ). The repulsive interaction between T31 and the imidazole ring of H163e blocks any access to the active site of the enzyme.
The tight interaction of loop L4 with the enzyme is based on formation of an intermolecular antiparallel β-sheet. Three residues from chagasin, L65, G66 and A67, interact with cathepsin L residues from G68e through N66e (Fig. 2d ). This β-sheet formation is supported by two polar contacts, namely the side chain carbonyl Oδ1 atom of N66e forms a hydrogen bond (mediated by a chloride anion) with the main-chain N atom of G68, and the K63 amino group of chagasin interacts with the hydroxyl group of Y72e. Additionally, the main-chain G66 of chagasin forms a hydrogen bond with the main-chain carbonyl group of D162e from cathepsin L.
Loop L6 forms three different types of interactions with the enzyme: hydrogen bonds (R91), hydrophobic contacts (P92), and π interactions (W93) (Fig. 2e) . For the understanding of the intricate nature of these interactions it is important to first realize that the classical interpretation of the enzymatic apparatus of a cysteine protease as a catalytic triad (C25-H163-N187 in cathepsin L numbering) should be extended to include a fourth component of this system, namely a cluster of aromatic residues which serves to anchor the asparagine residue (N187e). This aromatic cluster includes a number of residues, two of which (W189e and W193e) provide N-H…π interactions for the anchoring of the N187e side-chain amide group (Fig. 2e) . The essence of the interactions of the chagasin L6 loop with the enzyme is in the recognition of the crucial residues in the catalytic cleft. Residue W93 becomes part of the enzyme's aromatic cluster through a C-H…π interaction with W193e. Another element of loop L6, R91, assumes a fully extended conformation reaching to the catalytic site and to loop L2, which is also present there.
The guanidinium group of R91 forms two H bonds with the carbonyl group of T32 in loop L2, which is located next to the active-site-blocking T31 (vide supra). The other segment of the guanidinium group of R91 forms a pair of H bonds with the side-chain C=O group of the enzyme's N18e residue. It is interesting to note that the equivalent position in cruzipain is occupied by an aspartate, making the interaction with R91 even better. Finally, the guanidinium group of R91 is also hydrogen bonded to the carbonyl group of G20e. The third element of L6, P92, serves to shape the loop for optimal interactions with the enzyme. It is located in a hydrophobic cavity formed by the side chains of F145e and L144e. In addition to the interactions of loop L6 described above, other contacts are mediated by water molecules. Wat37 forms three hydrogen bonds, with the side-chain nitrogen atom of W93, with the carbonyl oxygen atom of W189e, and with the carboxylate group of E192e. Wat133 bridges the edges of the loop by interacting with the hydroxyl group of T94 and with the main-chain nitrogen atom of R91.
The E141e residue, located at the edge of the catalytic groove of cathepsin L, forms two additional hydrogen bonds with two chagasin residues that do not belong to the L4-L2-L6
binding epitope. The first contact is formed with the hydroxyl group of Y37 from strand β4, and the second contact is a salt bridge formed with the fully extended side chain of K43 from loop L3 (Table 3) . These two strong hydrogen bonds may be responsible for the skewed approach of the inhibitor into the catalytic cleft, visible for example in Fig. 2a .
Inhibition mode presented by chagasin in comparison with cystatins
The most studied group of cysteine protease inhibitors are the cystatins, which are small proteins with a size of 10-12 kDa. 23 The mode of inhibition of cystatins can be described on the basis of the crystal structure of cystatin B (also called stefin B) in complex with papain (PDB code 1STF) 24 or cystatin A (also called stefin A) in complex with cathepsin H (PDB code 1NB5).
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For comparison with the chagasin cathepsin L complex, we decided to use the cystatin B-papain complex 24 rather than the cystatin A-cathepsin H complex, 25 because of the higher structural and enzymatic similarities of papain to cathepsin L and cruzipain.
Superposition of the chagasin-cathepsin L complex with that of cystatin B-papain complex 24 shows a completely different fold for the two inhibitors, namely the all-β structure of chagasin and a five-stranded antiparallel β-sheet wrapped around a long α-helix of the cystatin. Although both inhibitors use a three-element epitope for enzyme binding, the angle of approach for the bulk of the inhibitors is different (Fig. 3a) .
Despite of the lack of overall similarity of the inhibitors' sequences and structures, one notes a striking analogy of the inhibition mode and interactions of the three binding elements (Fig. 3b) .
First of all, however, one should note that the three-element epitopes of these two classes of enzymes have different topology. While the epitope of cystatins is sequential, i.e. consists of the N-terminus, loop L1 and loop L2 in this order, these elements are mapped, respectively, onto loops L4, L2, and L6 of chagasin.
The three crucial residues R91, P92, and W93 of loop L6 of chagasin correspond, respectively, to L102, P103, and H104 in the cystatin B molecule. It is noteworthy that the pattern Pro-aromatic is conserved in cystatins and in chagasin-like inhibitors, despite the lack of overall sequence similarity. The role of the proline residue seems to be to maintain the specific shape of the loop.
The aromatic residue, on the other hand, interacts with the aromatic cluster of the enzyme. The residue preceding the Pro-aromatic motif, which is invariably an arginine in chagasin-type inhibitors of protozoan origin, is replaced by an aliphatic residue in cystatins. This difference may be an important element regulating the enzyme specificity of these two groups in inhibitors.
The R91 residue of chagasin provides direct communication between loops L6 and L2, and also interacts with the crucial N18e of the cathepsin L molecule. An additional interaction between loops L2 and L6 of chagasin is provided by the carbonyl group of the main chain of M90 and the nitrogen atom of A35. A similar stabilizing contact between cystatin B loops L2 and L1 is formed by the main-chain carbonyl of Q101 and the peptide nitrogen of T58.
The interaction of loop L4 of chagasin with cathepsin L is based on an intermolecular β-sheet formation. There is an analogous interaction between the N terminus of cystatin B and papain (Fig. 3b) . G9 from the N terminus of cystatin B and G66 from loop L4 of chagasin provide a degree of flexibility, thus allowing for optimal interactions between the two main chains. The same role is played by G65e and G67e in papain and cathepsin L, respectively.
When structurally aligned in their respective enzyme complex structures, loops L2 of chagasin and L1 of cystatin B reveal a trace of sequence similarity. S28 from chagasin corresponds to S52
in cystatin B and G33 from chagasin maps onto G57 in cystatin B. The conformation of these two loops differs but, in both cases, there is a surprisingly small number of specific interactions with the catalytic residues of the enzyme. The repulsive interaction between chagasin and cathepsin L (vide supra) is reproduced in the cystatin complex as well.
Comparison of cathepsin L complexes of chagasin and p41
The complex of the p41 fragment of the invariant chain with cathepsin L (PDB code 1ICF) shows a mode of inhibition of papain-like cysteine proteases that is similar in principle but completely different in detail when compared to that displayed by cystatins. 9 The small p41 fragment consists of two subdomains, where the first one is composed of an α-helix and a β-strand and the second one of a three-stranded antiparallel β-sheet. Similarly to cystatins and chagasin, the molecule interacts with the enzyme through a wedge composed of three hairpin loops (Fig. 3a) .
When superimposing our chagasin-cathepsin L structure with that of the p41 fragment-cathepsin L complex, distinct differences in the binding mode of the inhibitors to the enzyme are seen (Fig.   3c ). Although the overall affinity for cathepsin L is very high and almost identical for chagasin and the p41 fragment, with K i of 3.9 (this work) and 1.7 pM, 8 respectively, the mode of interaction of the particular loops is different.
The largest difference is observed for the loop R248-H252 in the p41 fragment, which corresponds to loop L6 in chagasin. This loop is much shorter and interacts with the enzyme differently. Although the Pro-aromatic motif is missing in the p41 fragment, the guanidinium group of its R250 residue mimics the indole ring of W93 of chagasin. Analogously to the situation observed in the chagasin-cathepsin L complex, there is also an interaction between the inhibitory loops of the p41 fragment, namely, the loop formed by residues T247-N254 interacts with the middle loop via hydrogen bonds between the side chain atoms of R250 and the main chain carbonyls of I231 and G232, respectively.
The interaction motif of the loop in the p41 fragment that corresponds to loop L4 in chagasin is one residue shorter. In addition to the shortened loop, the rigidity of P209 residue (which maps onto L65 of chagasin), makes the intermolecular β-sheet less extensive. 
DISCUSSION
Comparison of different chagasin models
The present structures of free chagasin and chagasin in complex with cathepsin L, together with the recently published NMR and crystallographic models of free chagasin, 15, 16 allow a critical evaluation of the existing speculations concerning the chagasin structure and mechanism of inhibition.
Comparison with the NMR model
Although the general fold of the chagasin molecule determined in this study is the same as that derived from solution NMR measurements (PDB code 2FO8), 14 the r.m.s. deviation in Cα superposition with the first chain of the NMR ensemble is very high, approaching 3 Å (Table 3) .
Part of this high discrepancy can be related to the increased dynamic properties of the enzymebinding loops reported for the NMR model. Notably, no disorder of these loops is seen in any of the three crystallographic copies of chagasin. Furthermore, loops L2 and L6 show invariant and stable conformation, unaffected by enzyme binding. Loop L4 does undergo a conformational change upon complex formation and, indeed, it is this region that shows the highest mobility in the NMR model. However, this highly dynamic region seen in the NMR structure extends from residue P60 to G69, whereas G69 (in strand β6) in the crystallographic models forms antiparallel β-sheet hydrogen bonds with S28 of β3 (also disordered in the NMR model). The highest structural variability in the crystallographic models is seen at loop L3. In the NMR model, this region of the non-inhibitory end of the molecule is also characterized by increased dynamic properties.
Comparison with a crystallographic model obtained using different crystallization conditions
The coordinates corresponding to the structure of chagasin reported by Figueiredo da Silva et al. 15 were released by the PDB (PDB code 2H7W) during the final stage of preparation of this manuscript. The crystal used to determine that structure (referred to as the "PEG" structure) was grown from 15% PEG8000, 0.1 M ammonium sulfate, and 0.1 M cacodylate buffer at pH 6.5.
Despite the different crystallization conditions, the structure is almost isomorphous with that determined by us and described in this paper. The space group is the same for crystals obtained unit is slightly different due to contraction of the unit cell. The present structure is more complete and the model contains all residues, including all side chains. In the PEG structure, two residues at the N-terminus of chain A, one at the N-terminus, and one at the C-terminus of chain B are missing. Additionally, eight side chains have been truncated to alanine. The chagasin construct used for the PEG crystallization contained a His 6 -tag with an additional linker region of 17 residues, not visible in the structure. In the PDB-deposited structure 2H7W, residue 104 is isoleucine instead of the threonine present in the native chagasin sequence at this position (GenBank/EMBL Acc. No. AJ299433). 11 The 2H7W structure was refined with anisotropic atomic displacement parameters, although the resolution of the experimental data (1.7 Å) is too low to justify utilization of such a model. It must be stressed that despite the unwarranted proliferation of refined parameters, the 2H7W model is characterized by significantly worse R (20.7% vs 18.6%) and R free (23.8% vs 21.6%) factors. Since the structure of chagasin refined by us is complete and has superior statistical parameters, we have decided to include its discussion in this paper, and use it as a reference chagasin model.
Docking of chagasin in the active site of cruzipain
The complex described in the present study should be relevant to both physiology and pathology, as chagasin is present on the parasite surface or outside the cell, 12 where it can interact with human cysteine proteases, such as cathepsin L. Since cathepsin L is likely to be important in the host response to the invading parasite through its regulatory properties on antigen presentation, 8 it is possible that chagasin-mediated inhibition of cathepsin L improves the chances of survival for the parasite or that the parasite needs chagasin to regulate the action of its own cathepsin L-like cysteine protease, cruzipain. Superposition of the catalytic part of cruzipain 26 (PDB code 1ME3) on the cathepsin L molecule in its chagasin complex, shows a possible interaction mode of chagasin with the parasite enzyme. The catalytic pockets of cathepsin L and cruzipain are superposed almost perfectly (Fig. 4a) . This observation suggests that the interactions of loop L2
of chagasin in this area will be essentially identical for both enzymes.
The interaction of loop L4 of chagasin with cathepsin L is based on intramolecular β-sheet formation. The formation of the main-chain -main-chain hydrogen bonds is possible due to the presence of flexible glycine residues G67e and G68e in the cathepsin L molecule, which correspond to G65e and G66e in cruzipain. The additional polar contact between the amino group of K63 and the hydroxyl group Y72e can be maintained because N70e is present in this position in cruzipain. In support of the importance of this interaction, small-molecule inhibitors developed for cruzipain 26 adopt a conformation that is almost identical to that of loop L4 and create the same pattern of hydrogen bonds mimicking the antiparallel β-sheet (Fig. 4b) . 
Models of chagasin binding mode
Two recently published studies 14, 15 ethanolamine, pH 9.0, using a gradient of the same buffer containing 1M NaCl for elution. Purity of the recombinant chagasin was verified by SDS-PAGE (4-12%; Novex; Invitrogen AB, Stockholm, Sweden) and 1% agarose gel electrophoresis. 27 The fractions of highest chagasin concentration were pooled and dialyzed against 100 mM Hepes buffer at pH 7.0. The protein solution was concentrated using a Vivaspin column with a cut-off limit of 5 kDa (Vivascience, Lincoln, UK) to a final concentration of 8 mg/ml.
Production of Se-Met chagasin
Production of Se-Met containing chagasin was accomplished in the system described above. The plasmid was transformed into competent E. coli B834 (DE3) cells (Novagen, VWR International AB, Stockholm, Sweden). Single colonies were picked and grown in minimal medium, as described earlier. 28 The cells were centrifuged and resuspended in minimal medium containing Se-Met for expression. The culture was grown in 30 °C, induced with 0.1 mM IPTG, and incubated for 4 h. The cells were harvested by centrifugation and lysed by sonication. The protein was purified as described above and concentrated to 5 mg/ml. Successful Met→Se-Met substitution was confirmed with mass spectrometric analysis.
Production of recombinant human cathepsin L
By site-directed mutagenesis 29 the region coding for C25 in a wild-type human cathepsin L cDNA was mutated to an alanine codon using the oligonucleotide 5'-T CAG TGT GGT AGC GCT TGG GCT TTT AG-3' (mutated bases underlined). This mutation introduced an HaeII restriction site. The mutated cDNA was subcloned into the vector pPIC9 (Invitrogen; San Diego, CA, U.S.A) and introduced into the yeast P. pastoris, strain GS115 (Invitrogen), by electroporation. The mutant proenzyme was expressed by the yeast under similar conditions to those outlined by the manufacturer (Invitrogen) and to those previously described for the C25S/T110A mutant. 30 The culture medium was centrifuged and the resulting supernatant was concentrated using an Amicon YM10 membrane. The concentrated medium was dialyzed against 50 mM NaOAc, pH 4.7. After adjusting the pH to 5.0, the C25A procathepsin L mutant was 
Protein analyses
Protein concentration in preparations used for crystallization trials was estimated by Commassie Protein Assay (Pierce Biotechnology, Inc., Rockford, IL, USA). N-terminal sequencing was carried out after electrophoresis in agarose gels, blotting to a PVDF membrane (Millipore, Bedford, MA, USA) and staining with 0.05% Coomassie blue. Edman degradation was carried out by an Applied Biosystems 470A gas-liquid solid-phase sequenator at the Department of Clinical Chemistry, Malmö University Hospital, Sweden. MALDI-TOF mass spectrometry (Reflex III, Bruker) analysis was used to verify the correct mass of recombinant chagasin and SeMet chagasin as described earlier.
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Enzyme inhibition assays
Active site titration of papain (with E-64, using Bz-DL-Arg-NHPhNO 2 as substrate; Bachem Feinchemikalien, Bubendorf, Switzerland) and titration of the molar papain-inhibitory concentration of chagasin was accomplished as earlier described for cystatin analysis. 33 Active inhibitor concentrations determined in this way (as this is the method normally used for other cysteine protease inhibitors) were used for calculation of K i values. The fluorogenic substrate used for determination of equilibrium constants for dissociation (K i ) of complexes between chagasin and cathepsin L or other family C1 cysteine peptidases was Z-Phe-Arg-NHMec (10 mM; from Bachem) and the assay medium was 100 mM Na-phosphate buffer, pH 6.0, containing 1 mM dithiothreitol and 1 mM EDTA. Steady-state velocities were measured before and after addition of varying amounts of chagasin in assays at 37 °C, and K i values were calculated according to Henderson. 34 Corrections for substrate competition were made using K m values determined for the substrate batch used, under the assay conditions employed (60, 55, 3.2 and 1.9 µM for papain, cathepsin B, cathepsin L and cruzipain, respectively). To determine the association rate constant for the chagasin-cathepsin L interaction, the observed pseudo-first-order rate constants (k obs ) in continuous-rate assays with different concentrations of chagasin were determined by non-linear regression. The association rate constant (k on ) was then calculated from the slope of a plot of the k obs values vs. inhibitor concentrations.
Crystallization
All crystallization experiments were carried out at 18 °C using the hanging-drop vapor diffusion method. Initial screening for crystallization conditions of native chagasin was done using Crystal 
X-ray data collection and analysis
Chagasin: The measurements were performed at 100 K using the EMBL beamlines of the DESY synchrotron in Hamburg. For native chagasin, a data set with 1.7 Å resolution and with good statistics was recorded (Table 2) . Se-Met chagasin crystals showed inferior diffraction properties.
Smearing of the reflections was the most characteristic defect of the diffraction pattern. However, a crystal that was accidentally dropped into the well solution, and as a consequence dehydrated because of the high salt concentration, showed significant improvement of diffraction quality and was, in the end, used to collect MAD data. The diffraction data were indexed, integrated and scaled using the HKL program package. 35 Chagasin-cathepsin L complex: A crystal of the complex was obtained from the screen solution without further optimization. The crystal was small, around 0.15 mm long, but allowed collection of a 1.75 Å resolution data set. The diffraction data were collected using the X13 EMBL beamline of the DESY synchrotron. The crystal was flash-frozen in nitrogen gas stream at 100 K without additional cryoprotection. The images were indexed, integrated and scaled using the HKL program package. 35 Table 4 shows the statistics of data collection and processing.
Structure solution and refinement
Chagasin: The structure of chagasin was solved by the Se-Met MAD method, with full experimental details to be published elsewhere. The model derived from the initial Se-Metphased map was refined against a native data set extending to 1.70 Å resolution. The refinement was carried out with the Refmac5 program 36 from the CCP4 package 37 and included TLS parameters. Each chagasin molecule was divided into two rigid-body segments corresponding to the two β-sheets comprising the molecular core. Model rebuilding in the electron density maps was carried out using the program Coot. 38 Water molecules were either automatically identified by the ARP/wARP program 39 or manually introduced using the Coot software. The progress of the refinement was monitored and the model was validated using R free 40 . The side chains of a number of residues were modeled in double conformations. In addition, the main chain of the E39-T42 fragment of loop L3 in molecule A also had dual conformation. The quality of the final structure was assessed with PROCHECK. 41 The final statistics are shown in Table 4 .
Chagasin-cathepsin L complex:
The structure of the complex was solved by double molecular
replacement. An initial molecular-replacement solution (R=52.1%, correlation coefficient 55.9%) was obtained using the catalytic part of procathepsin L (PDB code 1CS8) as the search model in
MolRep. 42 The second run of molecular replacement used fixed contribution of the oriented and positioned cathepsin L molecule, whereas molecule A of the previously solved chagasin structure provided the search model (R=45.8%, correlation coefficient 61.7%). Manual model rebuilding was done subsequently using Coot. For refinement, the Refmac5 program was used with TLS parameters refined for cathepsin L and chagasin (two rigid-body segments defined as above).
Water molecules were either automatically identified by ARP/wARP or manually introduced using the Coot software. R free was monitored using a randomly chosen subset of reflections comprising 5% of the unique data set. The side chains of a number of surface residues were modeled in two conformations. The quality of the final structure was assessed with PROCHECK.
The final statistics are shown in Table 4 .
All crystallographic calculations were performed using the CCP4 suite of programs. Molecular illustrations were prepared using PyMOL. 
